The pharmaceutical industry has been receiving greater scrutiny lately due in large part to the many public and private legal enforcement actions taken against pharmaceutical manufacturers. These enforcement actions, along with legal developments such as the OIG Compliance Guidance for Pharmaceutical Manufacturers, the Sarbanes-Oxley Act's statutory guidelines for public corporations, the HIPAA...

New legislative and industry governance directives have sparked development of systems to tackle Information Lifecycle Management, and related compliance automation for regulations including Sarbanes-Oxley, Basel II and ISO 15489 records management. Many of these systems use a “store now, sort later” philosophy, whereas others capture related information in the context of business processes. Un...

Corporate accounting failures and regulatory proceedings that led to the enactment of the Sarbanes–Oxley Act of 2002 increased the scrutiny of auditors. We investigate whether these events resulted in a change in auditor behavior with respect to going concern reporting. Generally speaking, we find that non-Big N auditors became more conservative while Big N auditors became more accurate. Specif...